Evidence map›Paper›PMID 32820036›Full record

ArticleGenes & development2020

Functional loss of a noncanonical BCOR-PRC1.1 complex accelerates SHH-driven medulloblastoma formation.

Lena M Kutscher, Konstantin Okonechnikov, Nadja V Batora, Jessica Clark, Patricia B G Silva, Mikaella Vouri, Sjoerd van Rijn, Laura Sieber, Britta Statz, Micah D Gearhart and 17 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Mutations inScience advances · 2022
    Article
  12. Review
  13. Modeling Brain Tumors: A Perspective Overview ofFrontiers in molecular neuroscience · 2022
    Review
  14. Sonic Hedgehog Signaling in Cerebellar Development and Cancer.Frontiers in cell and developmental biology · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 8 institutions in 5 countries.

Lena M Kutscher *Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.ORCID 0000-0002-1130-4582
Konstantin Okonechnikov *Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Nadja V Batora *Hopp-Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Jessica ClarkHopp-Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Patricia B G SilvaHopp-Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Mikaella VouriHopp-Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Sjoerd van RijnHopp-Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Laura SieberHopp-Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Britta StatzHopp-Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Micah D GearhartDepartment of Genetics, Cell Biology, and Development, Masonic Cancer Center, Developmental Biology Center, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Ryo ShiraishiDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-0031, Japan.
Norman MackHopp-Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Brent A OrrDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Andrey KorshunovClinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Brian L GudenasDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Kyle S SmithDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Audrey L MercierInstitut Curie, PSL Research University, UMR 3347, Centre National de la Recherche Scientifique (CNRS), U1021, Institut National de la Santé et de la Recherche Médicale (INSERM), Orsay 91405, France.
Olivier AyraultInstitut Curie, PSL Research University, UMR 3347, Centre National de la Recherche Scientifique (CNRS), U1021, Institut National de la Santé et de la Recherche Médicale (INSERM), Orsay 91405, France.
Mikio HoshinoDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-0031, Japan.
Marcel KoolHopp-Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.ORCID 0000-0002-6557-5468
Katja von HoffDepartment for Paediatric Oncology and Haematology, Charité University Medicine, 13354 Berlin, Germany.
Norbert GrafDepartment for Pediatric Oncology and Hematology, Universitätsklinikum des Saarlandes, 66421 Homburg, Germany.
Gudrun FleischhackPediatric Haematology and Oncology, Pediatrics III, University Hospital of Essen, 45147 Essen, Germany.
Vivian J BardwellDepartment of Genetics, Cell Biology, and Development, Masonic Cancer Center, Developmental Biology Center, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Stefan M PfisterHopp-Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.
Paul A NorthcottDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Daisuke KawauchiHopp-Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.ORCID 0000-0002-1254-9725
German Cancer Research Center · DESt. Jude Children's Research Hospital · USNational Center of Neurology and Psychiatry · JPUniversité Paris-Sud · FRUniversity of Minnesota · USCharité - Universitätsmedizin Berlin · DEEssen University Hospital · DEUniversitätsklinikum des Saarlandes · DE

Funding

Molecular Basis of Action of the Putative Oncogene BCL6R01CA071540 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI BARDWELL, VIVIAN J · 2002 to 2012
$3.0M
Control of Trophoblast Differentiation in Placental DevelopmentR01HD084459 · NICHD · UNIVERSITY OF MINNESOTA · PI BARDWELL, VIVIAN J · 2016 to 2020
$1.7M
NCI NIH HHS R01 CA071540NICHD NIH HHS R01 HD084459
6 · The paper itself

Abstract

Medulloblastoma is a malignant childhood brain tumor arising from the developing cerebellum. In Sonic Hedgehog (SHH) subgroup medulloblastoma, aberrant activation of SHH signaling causes increased proliferation of granule neuron progenitors (GNPs), and predisposes these cells to tumorigenesis. A second, cooperating genetic hit is often required to push these hyperplastic cells to malignancy and confer mutation-specific characteristics associated with oncogenic signaling. Somatic loss-of-function mutations of the transcriptional corepressor

Indexed as

AnimalsCarcinogenesisCerebellar NeoplasmsDisease Models, AnimalGene Expression Regulation, NeoplasticHedgehog ProteinsHumansMedulloblastomaMiceMutationPatched-1 ReceptorPolycomb-Group ProteinsRepressor ProteinsSequence DeletionBcor protein, mouseHedgehog ProteinsPatched-1 ReceptorPolycomb-Group ProteinsRepressor ProteinsShh protein, mouseBCORbrain tumorcerebellar granule cellsmedulloblastomamouse modelPRC1.1 complex

Identifiers

PMID32820036
PMCPMC7462063
OpenAlexW3081335565

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.